Internal Medicine, Hematology & Oncology · Greenville, SC
NPI
1407851793
Since 2005
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
65 International Dr
Greenville, SC, 29615
Phone (864) 987-7000
Groups this clinician bills Medicare through
Medicare paid, 2024
$52K
787 services
Medicare patients, 2024
361
Average age 75
Drug cost, 2024
$2.1M
1,205 prescriptions
Company payments, 2025
$31.75
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kim O Gococo was code 99214 (office e&m - established), 730 times for 349 patients. In total Kim O Gococo billed 787 services in 5 codes, and Medicare paid $52K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-12-20.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 730 | 349 | $62.76 | $46K |
| 99215 Office E&M - Established | Office | 28 | 23 | $103.92 | $2,910 |
| 99205 Office E&M - New | Office | 16 | 16 | $130.67 | $2,091 |
By year: 2022 $67K for 983 services; 2023 $59K for 849 services; 2024 $52K for 787 services.
Medicare prescription drug claims, 2024
In 2024, the drug Kim O Gococo prescribed most often to Medicare patients was Anastrozole, with 515 prescriptions and refills. In total Kim O Gococo wrote 1,205 Medicare prescriptions that cost $2.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 515 | 1,457 | 164 | $8,351 |
| Tamoxifen Citrate Generic | 104 | 295 | 41 | $2,829 |
| Letrozole Generic | 68 | 178 | 21 | $1,593 |
| Exemestane Generic | 43 | 81 | Under 11 | $5,490 |
| Hydroxyurea Generic | 41 | 97 | 11 | $1,055 |
| Alendronate Sodium Generic | 32 | 71 | Under 11 | $187 |
| Orserdu Elacestrant Hcl | 26 | 26 | Under 11 | $585K |
| Verzenio Abemaciclib | 21 | 21 | Under 11 | $284K |
| Pegasys Peginterferon Alfa-2a | 20 | 20 | Under 11 | $86K |
| Ondansetron Hcl Generic | 20 | 20 | 16 | $163 |
| Gabapentin Generic | 16 | 37 | Under 11 | $147 |
| Piqray Alpelisib | 15 | 19 | Under 11 | $319K |
| Xarelto Rivaroxaban | 15 | 21 | Under 11 | $11K |
| Estradiol Generic | 14 | 41 | Under 11 | $872 |
| Potassium Chloride Generic | 14 | 26 | Under 11 | $223 |
Brand drugs: 166 claims; generic drugs: 1,039 claims; opioid claims: 16.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kim O Gococo $31.75 ($31.75 in general payments such as food, travel and fees) from 1 company. The largest payer was Abbvie Inc. with $31.75.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 1 | $31.75 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.